BG101692A - Means for the prophylaxy and treatment of iodine-deficiency states - Google Patents

Means for the prophylaxy and treatment of iodine-deficiency states

Info

Publication number
BG101692A
BG101692A BG101692A BG10169297A BG101692A BG 101692 A BG101692 A BG 101692A BG 101692 A BG101692 A BG 101692A BG 10169297 A BG10169297 A BG 10169297A BG 101692 A BG101692 A BG 101692A
Authority
BG
Bulgaria
Prior art keywords
iodine
deficiency
prophylaxy
treatment
organism
Prior art date
Application number
BG101692A
Other languages
Bulgarian (bg)
Other versions
BG62512B1 (en
Inventor
Веселина ЕДРЕВА
Галина ШОПОВА
Стефан АНТОНОВ
Стоян ШОПОВ
Original Assignee
"Шоан" ООД
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Шоан" ООД filed Critical "Шоан" ООД
Priority to BG101692A priority Critical patent/BG62512B1/en
Publication of BG101692A publication Critical patent/BG101692A/en
Publication of BG62512B1 publication Critical patent/BG62512B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The means can be used in particular in endemic goitre andother diseases caused by iodine deficiency in the organism. Themeans contains concentrate of mineral water having ionic contentfrom 10 to 1000 mg/l, phenylalanine-L-form, vitamin E andantimicrobial substance. It reduces the risk of overdosage ofiodine in the organism, and no unfavourable side effects areproduced. Iodine is introduced in the blood stream covering theiodine deficiency.2 claims
BG101692A 1997-06-27 1997-06-27 Means for prevention and treatment of iodine-deficient conditions BG62512B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG101692A BG62512B1 (en) 1997-06-27 1997-06-27 Means for prevention and treatment of iodine-deficient conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG101692A BG62512B1 (en) 1997-06-27 1997-06-27 Means for prevention and treatment of iodine-deficient conditions

Publications (2)

Publication Number Publication Date
BG101692A true BG101692A (en) 1999-06-30
BG62512B1 BG62512B1 (en) 2000-01-31

Family

ID=3927138

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101692A BG62512B1 (en) 1997-06-27 1997-06-27 Means for prevention and treatment of iodine-deficient conditions

Country Status (1)

Country Link
BG (1) BG62512B1 (en)

Also Published As

Publication number Publication date
BG62512B1 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
GB2327347B (en) Therapeutic and dietary compositions
AU1610495A (en) Monitoring water treatment agent in-system concentration and regulating dosage
AP9801392A0 (en) Concentrated antibody preparation.
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
TW250435B (en)
MY120802A (en) Absorbent article.
NZ332721A (en) Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders
FI970747A0 (en) Combination preparations for use in immunological diseases
EP0909561A3 (en) Use of reboxetine for the treatment of attention-deficit/hyperactivity disorder
AU5845099A (en) Use of (pex) in the treatment of metabolic bone diseases
MY164077A (en) Compositions and uses of et743 for treating cancer
GB9912159D0 (en) Improvements in and relating to the treatment of water
GB8412595D0 (en) Chlorination device
BG101692A (en) Means for the prophylaxy and treatment of iodine-deficiency states
NZ512289A (en) Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases
AU1664392A (en) Improvements in or relating to water treatment devices
RU93048600A (en) NATURAL MULTI-VITAMIN COMPLEX "LEVETON"
MXPA02005649A (en) Combinations of (s)-2 -(benzylamino -methyl)-2, 3, 8, 9, -tetrahydro-7h -1, 4-dioxino(2, 3)-e indol -8-one and neuroleptics.
WO2000010590A3 (en) Cancer treatment
FI972637A0 (en) Use of vitamin K in the treatment of hyperthyroidism
ZA9610264B (en) Preparation for use in the treatment of skin disorders.
FR2831540B1 (en) ISOLATED PEPTIDE FROM THE HEPATOCYTA GROWTH FACTOR AND ITS VARIANTS, METHOD OF PREPARATION AND THERAPEUTIC USE AS ANTIANGIOGENIC AGENTS
MD1962G2 (en) Method of treatment of oral candidiasis
WO2001072955A3 (en) Regulation of human nedd1-related protein
UA6536A (en) Massaging lubricant